Profile data is unavailable for this security.
About the company
LENSAR, Inc. is a commercial-stage medical device company. The Company is focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the procedure. Its product portfolio includes the LENSAR Laser System (LLS), and the ALLY Robotic Cataract Laser Treatment System (ALLY). The Company has developed its ALLY Robotic Cataract Laser System as a compact, ergonomic system utilizing a fast dual-modality laser and integrating artificial intelligence (AI) into proprietary imaging and software. ALLY is designed to transform cataract surgery by utilizing the Company’s advanced robotic technologies with the ability to perform the entire procedure in a sterile operating room or in-office surgical suite, delivering operational efficiencies and reduced overhead. ALLY includes its proprietary Streamline software technology, designed to guide surgeons to achieve better outcomes.
- Revenue in USD (TTM)59.14m
- Net income in USD-51.52m
- Incorporated2004
- Employees140.00
- LocationLENSAR Inc2800 Discovery Drive, Suite 100ORLANDO 32826United StatesUSA
- Fax+1 (302) 655-5049
- Websitehttps://www.lensar.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Treace Medical Concepts Inc | 218.88m | -50.11m | 118.52m | 477.00 | -- | 1.33 | -- | 0.5415 | -0.7947 | -0.7947 | 3.48 | 1.40 | 1.07 | 1.04 | 7.66 | 458,865.80 | -24.47 | -24.03 | -30.34 | -29.17 | 79.87 | 80.99 | -22.89 | -24.97 | 2.36 | -22.69 | 0.3829 | -- | 11.89 | 39.65 | -12.55 | -- | 57.11 | -- |
| Pro-Dex Inc | 70.23m | 11.19m | 126.57m | 181.00 | 11.78 | 3.10 | 10.17 | 1.80 | 3.35 | 3.35 | 21.03 | 12.73 | 1.18 | 2.65 | 4.40 | 388,016.60 | 18.87 | 12.06 | 23.88 | 15.24 | 28.09 | 29.81 | 15.94 | 11.73 | 2.14 | -- | 0.2418 | 0.00 | 23.68 | 13.84 | 322.10 | 7.99 | 19.14 | -- |
| CVRx Inc | 55.97m | -52.02m | 130.24m | 206.00 | -- | 2.70 | -- | 2.33 | -2.02 | -2.02 | 2.18 | 1.83 | 0.4684 | 0.7458 | 6.49 | 271,694.20 | -43.53 | -37.08 | -47.98 | -40.02 | 84.49 | 81.33 | -92.95 | -151.18 | 8.60 | -8.49 | 0.5072 | -- | 30.53 | 52.31 | -45.55 | -- | 66.61 | -- |
| LifeMD Inc | 252.34m | -7.71m | 133.82m | 304.00 | -- | 98.54 | 27.10 | 0.5303 | -0.1711 | -0.1711 | 5.66 | 0.0282 | 3.64 | 10.83 | 33.00 | 830,075.60 | -4.29 | -109.71 | -31.14 | -396.03 | 86.96 | 85.59 | -1.18 | -33.12 | 0.6645 | 0.3164 | 0.00 | -- | 39.27 | 76.32 | 7.23 | -- | -- | -- |
| Fonar Corp | 105.43m | 6.99m | 136.36m | 535.00 | 17.81 | 0.6949 | 9.72 | 1.29 | 1.04 | 1.04 | 15.74 | 26.69 | 0.4897 | 22.33 | 1.28 | 197,073.50 | 4.34 | 6.77 | 4.42 | 7.19 | 41.07 | 45.46 | 8.86 | 13.74 | 8.46 | -- | 0.0021 | -- | 1.43 | 4.02 | -21.26 | 0.1719 | -12.96 | -- |
| LENSAR Inc | 59.14m | -51.52m | 146.08m | 140.00 | -- | -- | -- | 2.47 | -4.39 | -4.39 | 4.99 | -1.02 | 0.8946 | 1.79 | 11.51 | 422,435.70 | -77.94 | -32.69 | -121.49 | -38.95 | 46.15 | 51.51 | -87.12 | -54.77 | 0.6671 | -- | -- | -- | 26.87 | 11.87 | -118.34 | -- | -40.48 | -- |
| Anika Therapeutics Inc | 82.20m | 13.91m | 147.24m | 288.00 | 10.84 | 1.00 | 7.28 | 1.79 | 0.9419 | -2.28 | 5.70 | 10.18 | 0.3907 | 0.486 | 3.25 | 285,430.60 | 6.61 | -1.87 | 7.39 | -2.06 | 54.29 | 60.74 | 16.92 | -4.73 | 4.47 | -- | 0.00 | -- | -0.7327 | 0.9077 | -156.70 | -- | 24.14 | -- |
| Apyx Medical Inc | 47.90m | -14.54m | 152.57m | 220.00 | -- | 24.06 | -- | 3.19 | -0.3644 | -0.3644 | 1.19 | 0.1546 | 0.8113 | 1.97 | 3.68 | 217,736.40 | -24.60 | -27.67 | -29.90 | -33.35 | 62.65 | 64.81 | -30.32 | -43.61 | 3.61 | -2.04 | 0.8507 | -- | -8.11 | 11.24 | -25.38 | -- | -11.11 | -- |
| InfuSystem Holdings Inc | 141.05m | 5.52m | 153.33m | 502.00 | 28.82 | 2.76 | 8.09 | 1.09 | 0.2616 | 0.2616 | 6.65 | 2.73 | 1.38 | 10.25 | 5.79 | 280,984.10 | 5.41 | 4.50 | 6.56 | 5.46 | 55.35 | 55.24 | 3.92 | 3.86 | 1.60 | 7.73 | 0.274 | 0.00 | 7.22 | 10.70 | 168.92 | 11.50 | -4.62 | -- |
| Cibus Inc | 3.79m | -118.90m | 156.17m | 157.00 | -- | 2.40 | -- | 41.16 | -3.26 | -3.26 | 0.0972 | 0.9588 | 0.0109 | -- | 4.23 | 24,165.61 | -36.11 | -80.24 | -39.32 | -89.98 | -- | -- | -3,322.54 | -1,268.46 | -- | -2.18 | 0.8131 | -- | 134.56 | -10.19 | 6.07 | -- | -22.92 | -- |
| Inogen Inc | 347.03m | -25.38m | 156.38m | 766.00 | -- | 0.7931 | -- | 0.4506 | -1.00 | -1.00 | 13.47 | 7.26 | 1.13 | 7.92 | 9.30 | 453,039.20 | -8.28 | -11.40 | -10.67 | -13.50 | 44.76 | 44.22 | -7.31 | -13.82 | 2.75 | -- | 0.00 | -- | 6.35 | -1.49 | 64.97 | -- | 38.15 | -- |
| Nano-X Imaging Ltd | 12.30m | -55.71m | 157.80m | 165.00 | -- | 0.9513 | -- | 12.83 | -0.8839 | -0.8839 | 0.195 | 2.40 | 0.0683 | 13.17 | 7.18 | 74,557.58 | -30.95 | -28.17 | -33.30 | -31.20 | -98.04 | -- | -452.82 | -1,072.25 | 3.93 | -- | 0.0201 | -- | 13.91 | -- | 11.95 | -- | 85.79 | -- |
| Acme United Corp | 194.96m | 10.02m | 168.37m | 633.00 | 18.17 | 1.45 | 10.36 | 0.8636 | 2.43 | 2.43 | 47.35 | 30.41 | 1.15 | 2.03 | 6.35 | 307,993.70 | 5.92 | 7.26 | 6.81 | 8.54 | 39.51 | 36.34 | 5.14 | 5.68 | 1.75 | 8.57 | 0.1962 | 18.40 | 1.56 | 6.42 | -43.67 | 12.70 | 33.59 | 4.56 |
| Citrine Global Corp | 0.00 | -1.74m | 169.70m | 18.00 | -- | -- | -- | -- | -0.0016 | -0.0016 | 0.00 | -0.0031 | 0.00 | -- | -- | 0.00 | -118.80 | -238.43 | -- | -- | -- | -- | -- | -186,483.40 | -- | -2.10 | -- | -- | -- | -- | 25.99 | -- | -- | -- |
| Accendra Health Inc | 6.71bn | -410.53m | 173.26m | 13.50k | -- | -- | -- | 0.0258 | -5.33 | -17.41 | 86.97 | -5.56 | 1.47 | 7.59 | 15.52 | 496,837.20 | -9.01 | -0.3346 | -17.40 | -0.5248 | 26.13 | 18.20 | -6.12 | -0.146 | 0.8386 | 1.67 | 1.25 | -- | 3.55 | 3.04 | -778.15 | -- | 34.30 | -- |
| Rapid Micro Biosystems Inc | 30.52m | -44.29m | 173.30m | 163.00 | -- | 3.91 | -- | 5.68 | -0.9984 | -0.9984 | 0.6884 | 1.00 | 0.3209 | 1.33 | 6.40 | 187,257.70 | -46.56 | -38.13 | -56.14 | -43.36 | 7.72 | -27.98 | -145.11 | -253.02 | 2.95 | -- | 0.3003 | -- | 24.57 | 11.18 | 10.63 | -- | -4.24 | -- |
Data as of Feb 13 2026. Currency figures normalised to LENSAR Inc's reporting currency: US Dollar USD
34.92%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| North Run Capital LPas of 24 Oct 2025 | 1.10m | 9.21% |
| Brandes Investment Partners LPas of 30 Sep 2025 | 777.70k | 6.51% |
| BlackRock Fund Advisorsas of 30 Sep 2025 | 575.56k | 4.82% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 446.55k | 3.74% |
| Cr�dit Mutuel Asset Management SAas of 31 Dec 2025 | 308.21k | 2.58% |
| Dimensional Fund Advisors LPas of 30 Sep 2025 | 220.70k | 1.85% |
| Geode Capital Management LLCas of 30 Sep 2025 | 217.89k | 1.82% |
| Tudor Investment Corp.as of 30 Sep 2025 | 210.55k | 1.76% |
| CSS LLCas of 30 Sep 2025 | 183.07k | 1.53% |
| Yakira Capital Management, Inc.as of 30 Sep 2025 | 129.45k | 1.08% |
More ▼
Data from 30 Sep 2025 - 05 Jan 2026Source: FactSet Research Systems Inc.
